{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:33:47Z","timestamp":1787495627739,"version":"build-2736575974"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T00:00:00Z","timestamp":1754611200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T00:00:00Z","timestamp":1754611200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82370225"],"award-info":[{"award-number":["82370225"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81700194"],"award-info":[{"award-number":["81700194"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Clinical and Translational Research Project of Anhui Province","award":["202427b10020064"],"award-info":[{"award-number":["202427b10020064"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-14527-6","type":"journal-article","created":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T11:11:28Z","timestamp":1754651488000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["MCP-1-CCR2-M2 macrophages axis contributes to diffuse large B-cell lymphoma progression and inhibits antitumor immune response"],"prefix":"10.1038","volume":"15","author":[{"given":"Zhao-Feng","family":"Wen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi-Tang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang-Yang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng-Ya","family":"Nan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Min","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,8]]},"reference":[{"key":"14527_CR1","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.anndiagpath.2018.09.014","volume":"38","author":"KE Grimm","year":"2019","unstructured":"Grimm, K. E. & O\u2019Malley, D. P. Aggressive B cell lymphomas in the 2017 revised WHO classification of tumors of hematopoietic and lymphoid tissues. Ann. Diagn. Pathol. 38, 6\u201310 (2019).","journal-title":"Ann. Diagn. Pathol."},{"issue":"3","key":"14527_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.beha.2018.07.014","volume":"31","author":"C Sarkozy","year":"2018","unstructured":"Sarkozy, C. & Sehn, L. H. Management of relapsed\/refractory DLBCL. Best PractRes Clin. Haematol. 31 (3), 209\u2013216 (2018).","journal-title":"Best PractRes Clin. Haematol."},{"issue":"3","key":"14527_CR3","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.ccr.2012.02.022","volume":"21","author":"D Hanahan","year":"2012","unstructured":"Hanahan, D. & Coussens, L. M. Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell. 21 (3), 309\u2013322 (2012).","journal-title":"Cancer Cell."},{"issue":"1","key":"14527_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00595-011-0058-8","volume":"42","author":"K Shirabe","year":"2012","unstructured":"Shirabe, K. et al. Role of tumor-associated macrophages in the progression of hepatocellular carcinoma. Surg. Today. 42 (1), 1\u20137 (2012).","journal-title":"Surg. Today"},{"issue":"2","key":"14527_CR5","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1159\/000012021","volume":"57","author":"I Takanami","year":"1999","unstructured":"Takanami, I., Takeuchi, K. & Kodaira, S. Tumor-associated macrophage infifiltration in pulmonary adenocarcinoma: association with angiogenesis and poor prognosis. Oncology 57 (2), 138\u2013142 (1999).","journal-title":"Oncology"},{"issue":"1","key":"14527_CR6","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1186\/s12885-019-6208-x","volume":"19","author":"YL Li","year":"2019","unstructured":"Li, Y. L., Shi, Z. H., Wang, X., Gu, K. S. & Zhai, Z. M. Tumor-associated macrophages predict prognosis in diffuse large B-cell lymphoma and correlation with peripheral absolute monocyte count. BMC Cancer. 19 (1), 1049 (2019).","journal-title":"BMC Cancer"},{"issue":"6186","key":"14527_CR7","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1126\/science.1252510","volume":"344","author":"RA Franklin","year":"2014","unstructured":"Franklin, R. A. et al. The cellular and molecular origin of tumor- associated macrophages. Science 344 (6186), 921\u2013925 (2014).","journal-title":"Science"},{"issue":"16","key":"14527_CR8","doi-asserted-by":"publisher","first-page":"2944","DOI":"10.1111\/febs.14466","volume":"285","author":"CE Hughes","year":"2018","unstructured":"Hughes, C. E. & Nibbs, R. J. B. A guide to chemokines and their receptors. FEBS J. 285 (16), 2944\u20132971 (2018).","journal-title":"FEBS J."},{"issue":"8","key":"14527_CR9","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/nrc3078","volume":"11","author":"ET Roussos","year":"2011","unstructured":"Roussos, E. T., Condeelis, J. S. & Patsialou, A. Chemotaxis in cancer. Nat. Rev. Cancer. 11 (8), 573\u2013587 (2011).","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"14527_CR10","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S1359-6101(99)00005-2","volume":"10","author":"E Van Coillie","year":"1999","unstructured":"Van Coillie, E., Van Damme, J. & Opdenakker, G. The MCP eotaxin subfamily of CC chemokines. Cytokine Growth Factor. Rev. 10 (1), 61\u201386 (1999).","journal-title":"Cytokine Growth Factor. Rev."},{"issue":"1","key":"14527_CR11","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1097\/MOH.0000000000000389","volume":"25","author":"V Bianconi","year":"2018","unstructured":"Bianconi, V., Sahebkar, A., Atkin, S. L. & Pirro, M. The regulation and importance of monocyte chemoattractant protein-1. Curr. Opin. Hematol. 25 (1), 44\u201351 (2018).","journal-title":"Curr. Opin. Hematol."},{"issue":"7","key":"14527_CR12","doi-asserted-by":"publisher","first-page":"2752","DOI":"10.1073\/pnas.91.7.2752","volume":"91","author":"IF Charo","year":"1994","unstructured":"Charo, I. F. et al. Molecular- cloning and functional expression of 2 monocyte chemoattractant protein-1 receptors reveals alternative splicing of the carboxyl-terminal Tails. Proc. Natl. Acad. Sci. USA. 91 (7), 2752\u20132756 (1994).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"9","key":"14527_CR13","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1161\/01.ATV.19.9.2085","volume":"19","author":"KSC Weber","year":"1999","unstructured":"Weber, K. S. C., Nelson, P. J., Grone, H. J. & Weber, C. Expression of CCR2 by endothelial cells implications for MCP-1 mediated wound injury repair and in vivo inflammatory activation of endothelium. Arterioscler. Thromb. Vasc Biol. 19 (9), 2085\u20132093 (1999).","journal-title":"Arterioscler. Thromb. Vasc Biol."},{"issue":"4","key":"14527_CR14","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.4049\/jimmunol.159.4.1993","volume":"159","author":"S Sozzani","year":"1997","unstructured":"Sozzani, S. et al. Receptor expression and responsiveness of human dendritic cells to a defined set of CC and CXC chemokines. J. Immunol. 159 (4), 1993\u20132000 (1997).","journal-title":"J. Immunol."},{"issue":"1","key":"14527_CR15","doi-asserted-by":"publisher","first-page":"e28305","DOI":"10.1371\/journal.pone.0028305","volume":"7","author":"L Izhak","year":"2012","unstructured":"Izhak, L. et al. Dissecting the autocrine and paracrine roles of the CCR2-CCL2 axis in tumor survival and angiogenesis. PLoS One. 7 (1), e28305 (2012).","journal-title":"PLoS One"},{"issue":"13","key":"14527_CR16","doi-asserted-by":"publisher","first-page":"15632","DOI":"10.18632\/oncotarget.6695","volume":"7","author":"J Yang","year":"2016","unstructured":"Yang, J. et al. CL2-CCR2 axis promotes metastasis of nasopharyngeal carcinoma by activating ERK1\/2-MMP2\/9 pathway. Oncotarget 7 (13), 15632\u201315647 (2016).","journal-title":"Oncotarget"},{"issue":"49","key":"14527_CR17","doi-asserted-by":"publisher","first-page":"34342","DOI":"10.1074\/jbc.M109.042671","volume":"284","author":"H Roca","year":"2009","unstructured":"Roca, H. et al. CCL2 and interleukin-6 promote survival of human CD11b\u2009+\u2009peripheral blood mononuclear cells and induce M2-Type macrophage polarization. J. Biol. Chem. 284 (49), 34342\u201334354 (2009).","journal-title":"J. Biol. Chem."},{"issue":"8","key":"14527_CR18","doi-asserted-by":"publisher","first-page":"385867","DOI":"10.4049\/jimmunol.1302821","volume":"192","author":"E Sierra-Filardi","year":"2014","unstructured":"Sierra-Filardi, E. et al. CCL2 shapes macrophage polarization by GM-CSF and M-CSF: identifification of CCL2\/CCR2-Dependent gene expression profifile. J. Immunol. 192 (8), 385867 (2014).","journal-title":"J. Immunol."},{"issue":"2","key":"14527_CR19","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s00277-018-3522-3","volume":"98","author":"YL Li","year":"2019","unstructured":"Li, Y. L., Shi, Z. H., Wang, X., Gu, K. S. & Zhai, Z. M. Prognostic signifificance of monocyte chemoattractant protein-1 and CC chemokine receptor 2 in diffuse large B cell lymphoma. Ann. Hematol. 98 (2), 413\u2013422 (2019).","journal-title":"Ann. Hematol."},{"issue":"23","key":"14527_CR20","doi-asserted-by":"publisher","first-page":"6101","DOI":"10.3390\/ijms20236101","volume":"20","author":"CH Lee","year":"2019","unstructured":"Lee, C. H. et al. MCP-1\/MCPIP-1 signaling modulates the effects of IL-1\u03b2in renal cell carcinoma through ER stress-mediated apoptosis. Int. J. Mol. Sci. 20 (23), 6101 (2019).","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"14527_CR21","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1038\/s41374-022-00824-5","volume":"102","author":"QQ Hu","year":"2022","unstructured":"Hu, Q. Q. et al. CC chemokine receptor 2 (CCR2) expression promotes diffuse large B-Cell lymphoma survival and invasion. Lab. Invest. 102 (12), 1377\u20131388 (2022).","journal-title":"Lab. Invest."},{"issue":"5","key":"14527_CR22","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144 (5), 646\u2013674 (2011).","journal-title":"Cell"},{"issue":"11","key":"14527_CR23","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1016\/j.ajpath.2019.07.007","volume":"189","author":"A Rani","year":"2019","unstructured":"Rani, A., Dasgupta, P. & Murphy, J. J. Prostate cancer: the role of inflammation and chemokines. Am. J. Pathol. 189 (11), 2119\u20132137 (2019).","journal-title":"Am. J. Pathol."},{"issue":"7","key":"14527_CR24","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/nrc1388","volume":"4","author":"F Balkwill","year":"2004","unstructured":"Balkwill, F. Cancer and the chemokine network. Nat. Rev. Cancer. 4 (7), 540\u2013550 (2004).","journal-title":"Nat. Rev. Cancer"},{"issue":"12","key":"14527_CR25","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1002\/pros.20464","volume":"66","author":"Y Lu","year":"2006","unstructured":"Lu, Y. et al. Monocyte chemotactic protein-1 (MCP-1) acts as a paracrine and autocrine factor for prostate cancer growth and invasion. Prostate 66 (12), 1311\u20131318 (2006).","journal-title":"Prostate"},{"issue":"4","key":"14527_CR26","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.fertnstert.2011.12.049","volume":"97","author":"MQ Li","year":"2012","unstructured":"Li, M. Q. et al. Chemokine CCL2 enhances survival and invasiveness of endometrial stromal cells in an autocrine manner by activating Akt and MAPK\/Erk1\/2 signal pathway. Fertil. Steril. 97 (4), 919\u2013929 (2012).","journal-title":"Fertil. Steril."},{"issue":"43","key":"14527_CR27","doi-asserted-by":"publisher","first-page":"36593","DOI":"10.1074\/jbc.M112.365999","volume":"287","author":"WB Fang","year":"2012","unstructured":"Fang, W. B. et al. CCL2\/CCR2 chemokine signaling coordinates survival and motility of breast cancer cells through Smad3 protein- and p42\/44 mitogen-activated protein kinase (MAPK)-dependent mechanisms. J. Biol. Chem. 287 (43), 36593\u201336608 (2012).","journal-title":"J. Biol. Chem."},{"issue":"3","key":"14527_CR28","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.3892\/ol.2016.4875","volume":"12","author":"C K\u00fcper","year":"2016","unstructured":"K\u00fcper, C., Beck, F-X. & Neuhofer, W. Autocrine MCP-1\/CCR2 signaling stimulates proliferation and migration of renal carcinoma cells. Oncol. Lett. 12 (3), 2201\u20132209 (2016).","journal-title":"Oncol. Lett."},{"issue":"2","key":"14527_CR29","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1158\/1541-7786.MCR-17-0308","volume":"16","author":"G Brummer","year":"2018","unstructured":"Brummer, G. et al. Chemokine signaling facilitates early- stage breast cancer survival and invasion through fibroblast-dependent mechanisms. Mol. Cancer Res. 16 (2), 296\u2013308 (2018).","journal-title":"Mol. Cancer Res."},{"issue":"1","key":"14527_CR30","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1111\/cas.13876","volume":"110","author":"A Natsagdorj","year":"2019","unstructured":"Natsagdorj, A. et al. CCL2 induces resistance to the antiproliferative effect of Cabazitaxel in prostate cancer cells. Cancer Sci. 110 (1), 279\u2013288 (2019).","journal-title":"Cancer Sci."},{"issue":"14","key":"14527_CR31","doi-asserted-by":"publisher","first-page":"5728","DOI":"10.1158\/0008-5472.CAN-09-4672","volume":"70","author":"K Movahedi","year":"2010","unstructured":"Movahedi, K. et al. Different tumor microenvironments contain functionally distinct subsets of macrophages derived from Ly6C(high) monocytes. Cancer Res. 70 (14), 5728\u20135739 (2010).","journal-title":"Cancer Res."},{"issue":"1","key":"14527_CR32","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12943-020-01165-x","volume":"19","author":"H Yang","year":"2020","unstructured":"Yang, H. et al. CCL2-CCR2 axis recruits tumor associated macrophages to induce immune evasion through PD-1 signaling in esophageal carcinogenesis. Mol. Cancer. 19 (1), 41 (2020).","journal-title":"Mol. Cancer"},{"issue":"1","key":"14527_CR33","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1136\/gutjnl-2015-310514","volume":"66","author":"X Li","year":"2017","unstructured":"Li, X. et al. Targeting of tumour-infiltrating macrophages via CCL2\/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma. Gut 66 (1), 157\u2013167 (2017).","journal-title":"Gut"},{"issue":"1","key":"14527_CR34","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/cas.14230","volume":"111","author":"D Li","year":"2020","unstructured":"Li, D. et al. Tumor-associated macrophages secrete CC-chemokine ligand 2 and induce Tamoxifen resistance by activating PI3K\/Akt\/mTOR in breast cancer. Cancer Sci. 111 (1), 47\u201358 (2020).","journal-title":"Cancer Sci."},{"issue":"3","key":"14527_CR35","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.ejim.2014.01.019","volume":"25","author":"O Markovic","year":"2014","unstructured":"Markovic, O. et al. Comparison of prognostic impact of absolute lymphocyte count, absolute monocyte count, absolute lymphocyte count\/absolute monocyte count prognostic score and ratio in patients with diffuse large B cell lymphoma. Eur. J. Intern. Med. 25 (3), 296\u2013302 (2014).","journal-title":"Eur. J. Intern. Med."},{"issue":"1","key":"14527_CR36","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12943-019-0976-4","volume":"18","author":"C Wei","year":"2019","unstructured":"Wei, C. et al. Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal Circulating tumor cell-mediated colorectal cancer metastasis. Mol. Cancer. 18 (1), 64 (2019).","journal-title":"Mol. Cancer"},{"issue":"5","key":"14527_CR37","doi-asserted-by":"publisher","first-page":"e003890","DOI":"10.1136\/jitc-2021-003890","volume":"10","author":"M Larroquette","year":"2022","unstructured":"Larroquette, M. et al. Spatial transcriptomics of macrophage infiltration in non-small cell lung cancer reveals determinants of sensitivity and resistance to anti-PD1\/PD-L1 antibodies. J. Immunother Cancer. 10 (5), e003890 (2022).","journal-title":"J. Immunother Cancer"},{"issue":"1","key":"14527_CR38","doi-asserted-by":"publisher","first-page":"1747340","DOI":"10.1080\/2162402X.2020.1747340","volume":"9","author":"AR Dancsok","year":"2020","unstructured":"Dancsok, A. R. et al. Tumor-associated macrophages and macrophage-related immune checkpoint expression in sarcomas. Oncoimmunology 9 (1), 1747340 (2020).","journal-title":"Oncoimmunology"},{"issue":"1","key":"14527_CR39","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1186\/s12957-021-02299-y","volume":"19","author":"T Xue","year":"2021","unstructured":"Xue, T. et al. Prognostic significance of CD163\u2009+\u2009tumor-associated macrophages in colorectal cancer. World J. Surg. Oncol. 19 (1), 186 (2021).","journal-title":"World J. Surg. Oncol."},{"issue":"18","key":"14527_CR40","doi-asserted-by":"publisher","first-page":"4970","DOI":"10.1158\/1078-0432.CCR-19-3890","volume":"26","author":"SJ Cowman","year":"2020","unstructured":"Cowman, S. J. et al. Macrophage HIF-1\u03b1is an independent prognostic indicator in kidney cancer. Clin. Cancer Res. 26 (18), 4970\u20134982 (2020).","journal-title":"Clin. Cancer Res."},{"issue":"8","key":"14527_CR41","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1038\/s41388-019-1090-1","volume":"39","author":"CY Sun","year":"2020","unstructured":"Sun, C. Y. et al. MCP-1\/CCR-2 axis in adipocytes and cancer cell respectively facilitates ovarian cancer peritoneal metastasis. Oncogene 39 (8), 1681\u20131695 (2020).","journal-title":"Oncogene"},{"issue":"7355","key":"14527_CR42","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/nature10138","volume":"475","author":"BZ Qian","year":"2011","unstructured":"Qian, B. Z. et al. CCL2 recruits inflammatory monocytes to facilitate breast tumour metastasis. Nature 475 (7355), 222\u2013225 (2011).","journal-title":"Nature"},{"issue":"2","key":"14527_CR43","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1159\/000445644","volume":"39","author":"C Wu","year":"2016","unstructured":"Wu, C. et al. Prognostic significance of monocytes and monocytic Myeloid-Derived suppressor cells in diffuse large B-Cell lymphoma treated with R-CHOP. Cell. Physiol. Biochem. 39 (2), 521\u2013530 (2016).","journal-title":"Cell. Physiol. Biochem."},{"issue":"7","key":"14527_CR44","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1038\/s41423-023-01013-0","volume":"20","author":"T Yoshimura","year":"2023","unstructured":"Yoshimura, T., Li, C., Wang, Y. & Matsukawa, A. The chemokine monocyte chemoattractant protein-1\/CCL2 is a promoter of breast cancer metastasis. Cell. Mol. Immunol. 20 (7), 714\u2013738 (2023).","journal-title":"Cell. Mol. Immunol."},{"issue":"1","key":"14527_CR45","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1038\/s41467-022-29647-0","volume":"13","author":"H Li","year":"2022","unstructured":"Li, H. et al. Targeting brain lesions of non-small cell lung cancer by enhancing CCL2-mediated CAR-T cell migration. Nat. Commun. 13 (1), 2154 (2022).","journal-title":"Nat. Commun."},{"issue":"3","key":"14527_CR46","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/nm.2328","volume":"17","author":"MJ Bissell","year":"2011","unstructured":"Bissell, M. J. & Hines, W. C. Why don\u2019t we get more cancer? A proposed role of the microenvironment in restraining cancer progression. Nat. Med. 17 (3), 320\u2013329 (2011).","journal-title":"Nat. Med."},{"issue":"4","key":"14527_CR47","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.it.2015.02.004","volume":"36","author":"R Ostuni","year":"2015","unstructured":"Ostuni, R., Kratochvill, F., Murray, P. J. & Natoli, G. Macrophages and cancer: from mechanisms to therapeutic implications. Trends Immunol. 36 (4), 229\u2013239 (2015).","journal-title":"Trends Immunol."},{"issue":"1","key":"14527_CR48","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.immuni.2014.06.010","volume":"41","author":"R Noy","year":"2014","unstructured":"Noy, R. & Pollard, J. W. Tumor-associated macrophages: from mechanisms to therapy. Immunity 41 (1), 49\u201361 (2014).","journal-title":"Immunity"},{"issue":"2","key":"14527_CR49","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/imm.12023","volume":"138","author":"XQ Tang","year":"2013","unstructured":"Tang, X. Q., Mo, C. F., Wang, Y. S., Wei, D. & Xiao, H. Y. Anti-tumour strategies aiming to target tumor-associated macrophages. Immunology 138 (2), 93\u2013104 (2013).","journal-title":"Immunology"},{"issue":"4","key":"14527_CR50","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1164\/rccm.201406-1137OC","volume":"191","author":"A Schmall","year":"2015","unstructured":"Schmall, A. et al. Macrophage and cancer cell cross- talk via CCR2 and CX3CR1 is a fundamental mechanism driving lung cancer. Am. J. Respir Crit. Care Med. 191 (4), 437\u2013447 (2015).","journal-title":"Am. J. Respir Crit. Care Med."},{"issue":"19","key":"14527_CR51","doi-asserted-by":"publisher","first-page":"4820","DOI":"10.1158\/1078-0432.CCR-18-0205","volume":"24","author":"T Kato","year":"2018","unstructured":"Kato, T. et al. Cancer-associated fibroblasts affect intratumoral CD8\u2009+\u2009and FoxP3\u2009+\u2009T cells via Interleukin 6 in the tumor microenvironment. Clin. Cancer Res. 24 (19), 4820\u20134833 (2018).","journal-title":"Clin. Cancer Res."},{"issue":"6","key":"14527_CR52","doi-asserted-by":"publisher","first-page":"8509","DOI":"10.1002\/jcp.27782","volume":"234","author":"B Farhood","year":"2019","unstructured":"Farhood, B., Najafi, M. & Mortezaee, K. CD8\u2009+\u2009cytotoxic T lymphocytes in cancer immunotherapy: A review. J. Cell. Physiol. 234 (6), 8509\u20138521 (2019).","journal-title":"J. Cell. Physiol."},{"issue":"3","key":"14527_CR53","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.1002\/jcp.27259","volume":"234","author":"M Najafi","year":"2019","unstructured":"Najafi, M. et al. Adjuvant chemotherapy with melatonin for targeting human cancers: A review. J. Cell. Physiol. 234 (3), 2356\u20132372 (2019).","journal-title":"J. Cell. Physiol."},{"issue":"10","key":"14527_CR54","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/s41577-018-0044-0","volume":"18","author":"J Borst","year":"2018","unstructured":"Borst, J., Ahrends, T., B\u0105ba\u0142a, N., Melief, C. J. M. & Kastenm\u00fcller, W. CD4\u2009+\u2009T cell help in cancer immunology and immunotherapy. Nat. Rev. Immunol. 18 (10), 635\u2013647 (2018).","journal-title":"Nat. Rev. Immunol."},{"issue":"2","key":"14527_CR55","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1053\/j.seminhematol.2010.01.011","volume":"47","author":"GJ Weiner","year":"2010","unstructured":"Weiner, G. J. Rituximab: mechanism of action. Semin Hematol. 47 (2), 115\u2013123 (2010).","journal-title":"Semin Hematol."},{"key":"14527_CR56","doi-asserted-by":"publisher","first-page":"368","DOI":"10.3389\/fimmu.2015.00368","volume":"6","author":"W Wang","year":"2015","unstructured":"Wang, W., Erbe, A. K., Hank, J. A., Morris, Z. S. & Sondel, P. M. NK Cell-Mediated Antibody-Dependent cellular cytotoxicity in cancer immunotherapy. Front. Immunol. 6, 368 (2015).","journal-title":"Front. Immunol."},{"issue":"16Pt1","key":"14527_CR57","first-page":"5866","volume":"9","author":"FJ Hernandez-Ilizaliturri","year":"2003","unstructured":"Hernandez-Ilizaliturri, F. J. et al. Neutrophils contribute to the biological antitumor activity of rituximab in a non-Hodgkin\u2019s lymphoma severe combined immunodeficiency mouse model. Clin. Cancer Res. 9 (16Pt1), 5866\u20135873 (2003).","journal-title":"Clin. Cancer Res."},{"issue":"7","key":"14527_CR58","doi-asserted-by":"publisher","first-page":"4415","DOI":"10.4049\/jimmunol.0713732","volume":"182","author":"M Leidi","year":"2009","unstructured":"Leidi, M. et al. M2 macrophages phagocytose rituximab- opsonized leukemic targets more efficiently than m1 cells in vitro. J. Immunol. 182 (7), 4415\u20134422 (2009).","journal-title":"J. Immunol."},{"issue":"2","key":"14527_CR59","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1111\/j.1365-2559.2011.04096.x","volume":"60","author":"N Wada","year":"2012","unstructured":"Wada, N. et al. Osaka lymphoma study group. Tumour- associated macrophages in diffuse large B-cell lymphoma: a study of the Osaka lymphoma study group. Histopathology 60 (2), 313\u2013319 (2012).","journal-title":"Histopathology"},{"issue":"1","key":"14527_CR60","first-page":"112","volume":"32","author":"M Wang","year":"2024","unstructured":"Wang, M. et al. [Expression of MCP-1 and CCR2 in newly diagnosed diffuse large B-Cell lymphoma and clinical significance]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 32 (1), 112\u2013119 (2024). Chinese.","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-14527-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-14527-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-14527-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T15:44:16Z","timestamp":1757346256000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-14527-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,8]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["14527"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-14527-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,8]]},"assertion":[{"value":"13 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"29044"}}